Angion Biomedica Corp.
Angion Biomedica Corp.（ANGN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
angn · 股价预测 · 4 位分析师（近3月）· FMP · 更新于 2024年4月30日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Hold
4 位分析师
共识
评级分布
12 个月目标价
High
$1.50
Consensus
$1.50
+50.0% upside
Low
$1.50
Median: $1.5 · Last Close: $1.00
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.05 | ↑ 5.00% |
1-day model range: $1.04–$1.06. Peak: $1.06 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ANGN · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-07-18 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2022-06-30 | Stifel | Downgrade ↓ | Buy→Hold |
| 2022-06-30 | Oppenheimer | Downgrade ↓ | Outperform→Perform |
| 2022-05-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-04-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-12-10 | Oppenheimer | Maintains | Outperform→Outperform |
| 2021-11-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-10-27 | Stifel | Maintains | Buy→Buy |
| 2021-03-02 | Cowen & Co. | Maintains | Outperform→Outperform |
| 2021-03-02 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Angion Biomedica Corp. (ANGN) stock. Of the recent 12 rating actions, 0 were upgrades and 3 were downgrades. 4 analysts currently cover ANGN.
分析师推荐趋势
ANGN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast ANGN EPS of $— for the current fiscal year, based on estimates from 0 analysts. The ANGN revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ANGN 股价预测由两类独立数据源支撑：来自 4 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ANGN 的共识目标价为 $1.50（+50.0% 上行空间），分析师共识为 Hold。
ANGN 的短期预测（明日）为 $1.05（+5.00%）。 ANGN 对 2027 年的股价预测均值为 $1。 ANGN 对 2030 年的预测区间为 $0–$0。
Angion Biomedica Corp. 在 NASDAQ 上市，代码 ANGN。ANGN 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 25% 对应 Hold 共识。
常见问题
ANGN 预测 · 8 个问题根据 4 位华尔街分析师，ANGN 的 12 个月平均目标价为 $1.50，最高 $1.50、最低 $1.50。若有图表，中位目标价可在上方查看。相对当前价 $1.00，隐含约 +50.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.